Compounds > 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one
Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Sclerosis, Systemic

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Sclerosis, Systemic in 2 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamane, K2
Ihn, H2
Kubo, M1
Tamaki, K2

Other Studies

2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Sclerosis, Systemic

ArticleYear
Increased transcriptional activities of transforming growth factor beta receptors in scleroderma fibroblasts.
    Arthritis and rheumatism, 2002, Volume: 46, Issue:9

    Topics: Activin Receptors, Type I; Cells, Cultured; Chromones; Collagen Type I; Enzyme Inhibitors; Fibroblas

2002
Epidermal growth factor up-regulates expression of transforming growth factor beta receptor type II in human dermal fibroblasts by phosphoinositide 3-kinase/Akt signaling pathway: Resistance to epidermal growth factor stimulation in scleroderma fibroblast
    Arthritis and rheumatism, 2003, Volume: 48, Issue:6

    Topics: Androstadienes; Cells, Cultured; Chromones; Dactinomycin; Dermis; Dose-Response Relationship, Drug;

2003